The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Open accessAbstract
SUMMARY Detailed studies of the broadly neutralizing antibodies (bNAbs) that underlie the best available examples of the humoral immune response to HIV are providing important information for the development of therapies and prophylaxis for HIV-1 infection. Here, we report a CD4-binding site (CD4bs) antibody, named N6, that potently neutralized 98% of HIV-1 isolates, including 16 of 20 that were resistant to other members of its class. N6 evolved a mode of recognition such that its binding was not impacted by the loss of individual contacts across the immunoglobulin heavy chain. In addition, structural analysis revealed that the orientation of N6 permitted it to avoid steric clashes with glycans, which is a common mechanism of resistance. Thus, an HIV-1-specific bNAb can achieve potent, near-pan neutralization of HIV-1, making it an attractive candidate for use in therapy and prophylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationRapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Self-citationSimek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Sather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Stewart-Jones, G. B. E., Soto, C., Lemmin, T., Chuang, G.-Y., Druz, A., Kong, R., Thomas, P. V., Wagh, K., Zhou, T., Behrens, A.-J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.010 · Cited by 404
Self-citationAntibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Self-citationIncreasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Klein, F., Gao, H., Gnanapragasam, P. N. P., Abadir, A., Seaman, M. S., Nussenzweig, M. C., et al. (2011) · Science · doi:10.1126/science.1213782 · Cited by 375
Self-citationZhou, T., Zhu, J., Wu, X., Moquin, S., Zhang, B., Acharya, P., Georgiev, I. S., Altae-Tran, H. R., Chuang, G.-Y., Joyce, M. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.012 · Cited by 366
Self-citationDoria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S. A., Wyatt, R. T., Korber, B. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01482-09 · Cited by 336
Self-citationStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Zhou, T., Lynch, R. M., Chen, L., Acharya, P., Wu, X., Doria-Rose, N. A., Joyce, M. G., Lingwood, D., Soto, C., Bailer, R. T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.007 · Cited by 310
Self-citationRapid development of broadly influenza neutralizing antibodies through redundant mutations
Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N. L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. (2014) · Nature · doi:10.1038/nature13764 · Cited by 296
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
Moore, P. L., Gray, E. S., Wibmer, C. K., Bhiman, J. N., Nonyane, M., Sheward, D. J., Hermanus, T., Bajimaya, S., Tumba, N. L., Abrahams, M.-R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2985 · Cited by 285
Self-citationRudicell, R. S., Kwon, Y. D., Ko, S.-Y., Pegu, A., Louder, M. K., Georgiev, I. S., Wu, X., Zhu, J., Boyington, J. C., Chen, X., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02213-14 · Cited by 282
Self-citationCooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
Gao, F., Bonsignori, M., Liao, H.-X., Kumar, A., Xia, S.-M., Lu, X., Cai, F., Hwang, K.-K., Song, H., Zhou, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.022 · Cited by 279
Self-citationMechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
Li, Y., O'Dell, S., Walker, L. M., Wu, X., Guenaga, J., Feng, Y., Schmidt, S. D., McKee, K., Louder, M. K., Ledgerwood, J. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00754-11 · Cited by 235
Self-citationMaturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
Wu, X., Zhang, Z., Schramm, C. A., Joyce, M. G., Do Kwon, Y., Zhou, T., Sheng, Z., Zhang, B., O’Dell, S., McKee, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.004 · Cited by 231
Self-citationDelineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
Georgiev, I. S., Doria-Rose, N. A., Zhou, T., Do Kwon, Y., Staupe, R. P., Moquin, S., Chuang, G.-Y., Louder, M. K., Schmidt, S. D., Altae-Tran, H. R., et al. (2013) · Science · doi:10.1126/science.1233989 · Cited by 212
Self-citationGarces, F., Lee, J. H., de Val, N., Torrents de la Pena, A., Kong, L., Puchades, C., Hua, Y., Stanfield, R. L., Burton, D. R., Moore, J. P., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.007 · Cited by 189
Wibmer, C. K., Bhiman, J. N., Gray, E. S., Tumba, N., Abdool Karim, S. S., Williamson, C., Morris, L., & Moore, P. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003738 · Cited by 185
Determinants of HIV-1 broadly neutralizing antibody induction
Rusert, P., Kouyos, R. D., Kadelka, C., Ebner, H., Schanz, M., Huber, M., Braun, D. L., Hozé, N., Scherrer, A., Magnus, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4187 · Cited by 176
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
Sommerstein, R., Flatz, L., Remy, M. M., Malinge, P., Magistrelli, G., Fischer, N., Sahin, M., Bergthaler, A., Igonet, S., ter Meulen, J., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005276 · Cited by 174
Isolation of human monoclonal antibodies from peripheral blood B cells
Huang, J., Doria-Rose, N. A., Longo, N. S., Laub, L., Lin, C.-L., Turk, E., Kang, B. H., Migueles, S. A., Bailer, R. T., Mascola, J. R., et al. (2013) · Nature Protocols · doi:10.1038/nprot.2013.117 · Cited by 168
Self-citationPolyreactivity and Autoreactivity among HIV-1 Antibodies
Liu, M., Yang, G., Wiehe, K., Nicely, N. I., Vandergrift, N. A., Rountree, W., Bonsignori, M., Alam, S. M., Gao, J., Haynes, B. F., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02378-14 · Cited by 162
Self-citationCrooks, E. T., Tong, T., Chakrabarti, B. K., Narayan, K. M., Georgiev, I. S., Menis, S., Huang, X., Kulp, D. W., Osawa, K., Muranaka, J., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004932 · Cited by 141
Self-citationLynch, R. M., Wong, P., Tran, L. M., O'Dell, S. J., Nason, M., Li, Y., Wu, X., & Mascola, J. R. (2015) · Journal of Virology · doi:10.1128/jvi.03608-14 · Cited by 141
Self-citationMacLeod, D. T., Choi, N. M., Briney, B. S., Garcés, F., Ver, L. S., Landais, E., Murrell, B., Wrin, T., Kilembe, W., Liang, C. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.016 · Cited by 139
Zlateva, K. T., Lemey, P., Vandamme, A., & Ranst, M. A. V. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4675-4683.2004 · Cited by 135
Structure of the Epstein-Barr virus major envelope glycoprotein
Szakonyi, G., Klein, M. G., Hannan, J. P., Young, K. A., Ma, R. Z., Asokan, R., Holers, V. M., & Chen, X. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1161 · Cited by 119
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
Diskin, R., Klein, F., Horwitz, J. A., Halper-Stromberg, A., Sather, D. N., Marcovecchio, P., Lee, T., West, A. P., Gao, H., Seaman, M. S., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130221 · Cited by 110
Self-citationGlycosylation Focuses Sequence Variation in the Influenza A Virus H1 Hemagglutinin Globular Domain
Das, S. R., Puigbò, P., Hensley, S. E., Hurt, D. E., Bennink, J. R., & Yewdell, J. W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001211 · Cited by 101
Broadly Neutralizing Antibodies for HIV Eradication
Stephenson, K. E., & Barouch, D. H. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0299-7 · Cited by 89
Wu, X., Wang, C., O'Dell, S. J., Li, Y., Keele, B. F., Yang, Z., Imamichi, H., Doria‐Rose, N. A., Hoxie, J. A., Connors, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07139-11 · Cited by 87
Self-citationNew approaches to HIV vaccine development
Haynes, B. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.05.007 · Cited by 84
Self-citationEnhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
Klein, F., Nogueira, L., Nishimura, Y., Phad, G. E., West, A. P., Halper-Stromberg, A., Horwitz, J. A., Gazumyan, A., Liu, C., Eisenreich, T., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20141050 · Cited by 82
Self-citationAntibody engineering for increased potency, breadth and half-life
Sievers, S. A., Scharf, L., West, A. P., & Björkman, P. J. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000148 · Cited by 60
Cited by
Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA · doi:10.1001/jama.2018.8431 · Cited by 698
Cirelli, K. M., Carnathan, D. G., Nogal, B., Martin, J. T., Rodriguez, O. L., Upadhyay, A. A., Enemuo, C. A., Gebru, E. H., Choe, Y., Viviano, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.012 · Cited by 433
Recent progress in broadly neutralizing antibodies to HIV
Sok, D., & Burton, D. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0235-7 · Cited by 407
Abbott, R. K., Lee, J. H., Menis, S., Skog, P., Rossi, M., Ota, T., Kulp, D. W., Bhullar, D., Kalyuzhniy, O., Havenar-Daughton, C., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.11.023 · Cited by 336
Kreer, C., Zehner, M., Weber, T., Ercanoglu, M. S., Gieselmann, L., Rohde, C., Halwe, S., Korenkov, M., Schommers, P., Vanshylla, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.044 · Cited by 309
Metadata
- Authors
- Huang, J., Kang, B. H., Ishida, E., Zhou, T., Griesman, T., Sheng, Z., Wu, F., Doria-Rose, N. A., Zhang, B., McKee, K., O’Dell, S., Chuang, G.-Y., Druz, A., Georgiev, I. S., Schramm, C. A., Zheng, A., Joyce, M. G., Asokan, M., Ransier, A., Darko, S., Migueles, S. A., Bailer, R. T., Louder, M. K., Alam, S. M., Parks, R., Kelsoe, G., Von Holle, T., Haynes, B. F., Douek, D. C., Hirsch, V., Seaman, M. S., Shapiro, L., Mascola, J. R., Kwong, P. D., & Connors, M.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 45
- Issue
- 5
- Pages
- 1108-1121
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2551273870
- Cited by
- 369
- References
- 37
- FWCI
- 27.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.